Home › NDC Lookup › RxCUI directory › RxCUI 643127

Prednisolone 30 MG Disintegrating Oral Tablet — RxCUI 643127

RxNorm drug concept · Semantic clinical drug
RxCUI 643127 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI643127
Official namePrednisolone 30 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asprednisolone 30 MG (as prednisolone sodium phosphate 40.3 MG) Disintegrating Oral Tablet; prednisoLONE sodium phosphate 30 MG Disintegrating Oral Tablet
FDA products mapped6
Package NDCs mapped6
Reported Medicaid activity (SDUD)29 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Prednisolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Prednisolone is a steroid that calms inflammation and dials down an overactive immune system. Depending on what you're being treated for — whether that's an asthma flare, a skin co...
  • Why has my doctor prescribed prednisolone — what is it actually doing?
  • Please don't stop on your own — this is one of the most important things to know about prednisolone. When you take it for more than a short time, your adrenal glands slow down thei...
  • Can I stop taking prednisolone when I start feeling better?
📖 Read our full Prednisolone guide →

🕸️ Concept Web — How Prednisolone 30 MG Disintegrating Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Prednisolone 30 MG Disintegrating Oral Tablet RxCUI 643127

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Prednisolone 8638
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Orapred 285077
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Prednisolone Disintegrating Oral Tablet 379264
    • Prednisolone Disintegrating Oral Product 1295508
    • Prednisolone Oral Product 1165759
    • Prednisolone Pill 1156758
    • Prednisolone Disintegrating Oral Tablet [Orapred] 647126
    • Orapred Disintegrating Oral Product 1296584
    • Orapred Oral Product 1183438
    • Orapred Pill 1183439
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Prednisolone 30 MG SCDC · 643126
  • Prednisolone Disintegrating Oral Tablet SCDF · 379264
  • Prednisolone Disintegrating Oral Product SCDG · 1295508
  • Prednisolone Oral Product SCDG · 1165759
  • Prednisolone Pill SCDG · 1156758

Brand-Name Concepts

  • Prednisolone 30 MG Disintegrating Oral Tablet [Orapred] SBD · 668660
  • Prednisolone 30 MG [Orapred] SBDC · 668659
  • Prednisolone Disintegrating Oral Tablet [Orapred] SBDF · 647126
  • Orapred Disintegrating Oral Product SBDG · 1296584
  • Orapred Oral Product SBDG · 1183438
  • Orapred Pill SBDG · 1183439
  • Orapred BN · 285077

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 643127 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50742-0383-12 2 BLISTER PACK in 1 CARTON (50742-383-12) / 6 TABLET, ORALL... prednisolone sodium phosphate ODT Ingenus Pharmaceuticals, LLC 2025-09-15
50742-0384-12 2 BLISTER PACK in 1 CARTON (50742-384-12) / 6 TABLET, ORALL... prednisolone sodium phosphate ODT Ingenus Pharmaceuticals, LLC 2025-09-15
50742-0385-12 2 BLISTER PACK in 1 CARTON (50742-385-12) / 6 TABLET, ORALL... prednisolone sodium phosphate ODT Ingenus Pharmaceuticals, LLC 2025-09-15
59212-0700-12 2 BLISTER PACK in 1 CARTON (59212-700-12) / 6 TABLET, ORALL... Orapred ODT Advanz Pharma (US) Corp. 2020-06-30
59212-0701-12 2 BLISTER PACK in 1 CARTON (59212-701-12) / 6 TABLET, ORALL... Orapred ODT Advanz Pharma (US) Corp. 2020-06-30
59212-0702-12 2 BLISTER PACK in 1 CARTON (59212-702-12) / 6 TABLET, ORALL... Orapred ODT Advanz Pharma (US) Corp. 2020-06-30
Observed labelers: Advanz Pharma (US) Corp. (3) · Ingenus Pharmaceuticals, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.